BTC Health Ltd Registered · ASX:BTC
BTC Health Ltd Registered — Biotech Capital — Investor Presentation (May 2016)
17 slides from BTC Health Ltd Registered's investor presentation, May 18, 2016
Slide 1: Biotech Capital Limited Investor Presentation
For personal use only Biotech Capital Limited Investor Presentation 18 May 2016
Slide 2: Forward Looking Statement
Forward Looking Statement For personal use only This presentation contains forward looking statements that involve risks and uncertainties. Although we believe that the expectations and assumptions reflected in the forward looking statements are reasonable at this time, Biotech Capital can give no a
Slide 3: Company Snapshot
Company Snapshot For personal use only Stock code ASX: BTC – market cap approximately $18m Biotech Capital is registered as a Pooled Development Fund (PDF) under the Pooled Development Fund Act, 1992 Experienced Board with strong industry profile and PDF expertise Headquartered in Melbourne,
Slide 4: Pooled Development Fund Summary
Pooled Development Fund Summary For personal use only Shareholders are entitled to concessionary tax treatment in Australia for income and capital gains derived from their shareholding. Gains realised on the disposal of shares will not be included in an investor’s assessable income in Australia.
Slide 5: Strategy
Strategy For personal use only Provide capital and management expertise to high-growth Australian biotech, medtech and pharmaceutical companies. Expand group capabilities and extend into higher value-add investments Growth through disciplined investment in life-science businesses: Profession
Slide 6: Share price
Share price For personal use only Last 3 years share price movement
Slide 7: Shareholdings and financial position
Shareholdings and financial position For personal use only Cash reserves at 30 April 2016: $1.2m NTA at 30 April 2016: $3.2m Shares outstanding: 108.6 million Options outstanding: 2 million (exercise price - 15.9c) Closing price 17 May 2016: 16.5 cents 52 week range: 7.0 cents – 18.0 cents Board/man
Slide 8: Board
Board For personal use only Richard Treagus – Chairman Peter Jones – Non Executive Director Bruce Hancox – Non Executive Director Jon Pilcher – Non Executive Director Jennifer Herz – Non Executive Director Stuart Jones – Company Secretary
Slide 9: Investment criteria
Investment criteria For personal use only Life sciences – both individual technologies and businesses Competitive advantage with strong differentiation and protection Scalable into large, high growth markets Leverage investments through group expertise and resources Revenue generating with
Slide 10: Sensear overview
For personal use only Develops and manufactures best-in-class digital headsets for use with two- way radio and Bluetooth communication devices. Founded in 2006 – based on a partnership with University of Western Australia and Curtin University. Patented SENSTM technology enhances speech and su
Slide 11: Biointelect overview
For personal use only Consulting services for biopharmaceutical, medical device and diagnostics companies seeking to commercialise new technologies. Expertise in evaluating clinical, regulatory, and economic evidence to support highly targeted and effective market entry strategies. Develops op
Slide 12: Biointelect track record
For personal use only Founded in 2011 – team of consultants in EU, US, LATAM. Servicing 30 clients on more than 50 projects covering 12 different therapeutic areas with local, regional and global scope. Assignments include small molecules, biologics, vaccines, and more recently medical devices
Slide 13: Biointelect services: commercial evaluation
Biointelect services: commercial evaluation For personal use only Commercial strategy and resource allocation Strategic plans for start-up businesses and new product launches Development of target product profile and best business models Revenue and cost projections Market evaluation Assess
Slide 14: Biointelect services: scientific affairs
Biointelect services: scientific affairs For personal use only Regulatory Regulatory strategy, filings and labeling review Technical and risk management file preparation Vigilance systems Medical and commercial compliance Quality Management Compliance, training and systems Audits, manage
Slide 15: Biointelect services: medical affairs
Biointelect services: medical affairs For personal use only Medical need Epidemiology and disease burden analysis Stakeholder mapping for product advocacy Strategy for symposia, publications and congresses Expert insight Advisory boards and Key Opinion Leaders Expertise in driving policy c
Slide 16: Biointelect clients
Biointelect clients For personal use only 360KS TM
Slide 17: Biotech Capital Outlook
Biotech Capital Outlook For personal use only Continue to grow the Biointelect client base – local and international Expand the service offering: Business administration services – accounting, financial, secretarial and compliance Business Development and Partnering Assistance with capital